Founded in 2000, Intron Life Sciences operates in Agritech offering a range of probiotics and biotech products focused on enhancing the health of poultry, aquaculture, swine, and ruminants. The compan...
Funding stage:
Series A
Last funding:
30/09/2025
Total funding:
$10.00 Mn+
Revenue:
Investors
Intron Life Sciences: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders4
Latest Filing Date07 Oct 2025- Funding Events14
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Intron Life Sciences
As of 08 October 2025, Intron Life Sciences's equity is held by 4 shareholders, with the top three being India Life Sciences Fund III LLC, Murali Krishna P S, and Param Capital Research.
India Life Sciences Fund III LLC holds the largest stake in Intron Life Sciences at 58.0% as of 08 October 2025.
As of 08 October 2025, founders collectively hold 38.2% equity in Intron Life Sciences.
As of 08 October 2025, investors collectively hold 58.0% equity in Intron Life Sciences.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links